We are live on ! Find out more
SLDB icon

Solid Biosciences

90 hedge funds and large institutions have $145M invested in Solid Biosciences in 2024 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 35 increasing their positions, 20 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,279% more call options, than puts

Call options by funds: $2.38M | Put options by funds: $100K

75% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 20

1.94% less ownership

Funds ownership: 92.86%90.92% (-1.9%)

2% less funds holding

Funds holding: 9290 (-2)

11% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 18

42% less capital invested

Capital invested by funds: $250M → $145M (-$105M)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
90
Holders Change
-2
Holders Change %
-2.17%
% of All Funds
1.19%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
16
Increased
35
Reduced
20
Closed
18
Calls
$2.38M
Puts
$100K
Net Calls
+$2.28M
Net Calls Change
-$1.96M
Name Holding Trade Value Shares
Change
Change in
Stake
PD
101
Point72 (DIFC)
United Arab Emirates
-$19.3K -2,764 Closed
Royal Bank of Canada
102
Royal Bank of Canada
Ontario, Canada
-$11.7K -2,132 -97%
Carson Wealth (CWM LLC)
103
Carson Wealth (CWM LLC)
Nebraska
-$6.26K -1,140 -96%
S
104
SignatureFD
Georgia
-$300 -43 Closed
US Bancorp
105
US Bancorp
Minnesota
-$188 -27 Closed
Northwestern Mutual Wealth Management
106
Northwestern Mutual Wealth Management
Wisconsin
-$174 -25 Closed
CPA
107
Capital Performance Advisors
California
-$105 -15 Closed

SLDB Hedge Fund Activity: Q4 2024 in Review

90 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Solid Biosciences (SLDB) for Q4 2024, worth a combined $145M — down 42% from $250M a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of SLDB and 16 opened new positions — a net loss of 2 holders — while 20 trimmed existing stakes and 35 added.

The largest buyer was Siren LLC, adding an estimated $5.49M. The largest seller was ADAR1 Capital Management, cutting an estimated $5.47M.

  • 90 institutional investors held Solid Biosciences (SLDB) as of Q4 2024, down from 92 in Q3 2024.
  • Funds reported $145M of Solid Biosciences stock for Q4 2024, down 42% quarter-over-quarter.
  • 16 funds opened new Solid Biosciences positions in Q4 2024 and 18 closed out, a net change of -2 holders.
  • The largest Solid Biosciences buyer in Q4 2024 was Siren LLC, an estimated $5.49M added.
  • The largest Solid Biosciences seller in Q4 2024 was ADAR1 Capital Management, an estimated $5.47M sold.

Based on aggregated 13F filings for Q4 2024.